A Man with Abdominal Pain: Enough Evidence for Surgery?
- 1 August 2012
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 58 (8) , 1187-1190
Abstract
Over the next 18 months, the patient underwent a plethora of imaging studies. A series of conventional studies failed to provide an explanation for the increased ACTH, and ultimately a positron emission tomography/computed tomography (PET/CT) scan using a relatively new radiotracer, 68Ga-labeled 1,4,7,10-tetraazacyclododecane-N,N′,N′′,N′′′-tetraacetic acid-d-Phe1-Tyr3-octreotide (68Ga-DOTATOC), was performed (4). A 3.3-cm area in the head of the pancreas with an increased uptake of radiotracer was observed (Fig. 1). In light of the persistently increased ACTH concentration, this finding raised the suspicion of a pancreatic ACTH-secreting neuroendocrine tumor, a rare ectopic source of ACTH (3). Although MRI and conventional CT evaluations did not confirm the presence of a tumor, the patient was offered immediate surgical treatment. The patient declined the offer and subsequently sought second and third opinions at medical facilities in 2 different countries. In both facilities, a neuroendocrine tumor was deemed the likely cause of his problems, and surgery was again suggested. Wishing minimally invasive treatment, the patient contacted the Interventional Centre at our hospital, which offers laparoscopic resection of the pancreas.Keywords
This publication has 7 references indexed in Scilit:
- 68Ga-DOTATOC PET/CT and somatostatin receptor (sst1–sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmaxEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Adrenal insufficiency: etiology, diagnosis and treatmentCurrent Opinion in Endocrinology, Diabetes and Obesity, 2010
- Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumorsEndocrine-Related Cancer, 2010
- 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CTJournal of Nuclear Medicine, 2007
- Cushing’s diseasePituitary, 2006
- Immunometric Assay InterferenceClinical Chemistry, 2002
- Ectopic Adrenocorticotropic Hormone SyndromeEndocrine Reviews, 1994